Kidney Function Decline After COVID-19 Infection.

Kidney Function Decline After COVID-19 Infection.

Publication date: Dec 02, 2024

COVID-19 infection has been associated with acute kidney injury. However, its possible association with long-term kidney function is not well understood. To investigate whether kidney function decline accelerated after COVID-19 compared with after other respiratory tract infections. This cohort study used linked data from the Stockholm Creatinine Measurements (SCREAM) Project between February 1, 2018, and January 1, 2022, in Stockholm, Sweden. All hospitalized and nonhospitalized adults in the database with at least 1 estimated glomerular filtration rate (eGFR) measurement in the 2 years prior to a COVID-19 positive test result or pneumonia diagnosis were selected. Statistical analyses were conducted between June 2023 and October 2024. COVID-19 and pneumonia (including influenza). Mean annual change in eGFR after COVID-19 and after pneumonia was calculated with a linear regression model. The COVID-19 cohort comprised 134 565 individuals (74 819 females [55. 6%]; median [IQR] age, 51 [37-64] years). The pneumonia cohort consisted of 35 987 individuals (19 359 females [53. 8%]; median [IQR] age, 71 [56-81] years). The median (IQR) baseline eGFR was 94 (79-107) mL/min/1. 73m2 for the COVID-19 cohort and 79 (61-92) mL/min/1. 73m2 for the pneumonia cohort. After adjustment for covariates, both infections demonstrated accelerated annual eGFR decline, with greater magnitude of decline after COVID-19 (3. 4% [95% CI, 3. 2%-3. 5%] after COVID-19; 2. 3% [95% CI, 2. 1%-2. 5%] after pneumonia). This decline was more severe among individuals hospitalized for COVID-19 (5. 4%; 95% CI, 5. 2%-5. 6%) but remained similar among those hospitalized for pneumonia. This cohort study found an association between COVID-19 and accelerated decline in kidney function, particularly after hospitalization, compared with pneumonia. People who were hospitalized for COVID-19 should receive closer monitoring of kidney function to ensure early diagnosis and optimized management of chronic kidney disease to effectively prevent complications and further decline.

Open Access PDF

Concepts Keywords
June Acute Kidney Injury
Kidney Adult
Pneumonia Aged
Sweden Betacoronavirus
Cohort Studies
Coronavirus Infections
COVID-19
Creatinine
Creatinine
Female
Glomerular Filtration Rate
Humans
Kidney
Male
Middle Aged
Pandemics
Pneumonia, Viral
SARS-CoV-2
Sweden

Semantics

Type Source Name
disease MESH COVID-19
disease MESH Infection
disease MESH acute kidney injury
disease MESH respiratory tract infections
drug DRUGBANK Creatinine
disease MESH pneumonia
disease MESH influenza
disease MESH chronic kidney disease
disease MESH complications
disease MESH viral pneumonia
drug DRUGBANK Isoxaflutole
disease IDO history
disease MESH educational level
disease MESH hypertension
disease MESH cardiovascular diseases
disease MESH cancer
disease MESH comorbidity
disease IDO virulence
disease MESH respiratory tract disease
disease IDO immunosuppression
disease IDO intervention
disease MESH fibrosis
disease IDO cell
drug DRUGBANK Hexachlorophene
disease MESH death
disease MESH long COVID
drug DRUGBANK L-Asparagine

Original Article

(Visited 2 times, 1 visits today)